These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12821613)

  • 21. From Tritace to Tri-Plen - the South African journey.
    Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820
    [No Abstract]   [Full Text] [Related]  

  • 22. More than just hype.
    Shishkov W
    CMAJ; 2003 Jun; 168(13):1647; author reply 1647-8. PubMed ID: 12821617
    [No Abstract]   [Full Text] [Related]  

  • 23. [Added organ protection at little cost. Double savings with ACE inhibitors].
    MMW Fortschr Med; 2003 Nov; 145(48):63. PubMed ID: 14725008
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ
    Med Sci Monit; 2004 Dec; 10(12):SR23-8. PubMed ID: 15567997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Training for LCA (Hope study)].
    Gueyffier F
    Rev Prat; 2012 May; 62(5):687-9. PubMed ID: 22730805
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ramipril after myocardial infarct. Long lasting cardiovascular protective action].
    MMW Fortschr Med; 2003 Sep; 145(39):46. PubMed ID: 14649074
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood pressure and cardiovascular risk in the HOPE study.
    Taylor R
    Lancet; 2002 Jun; 359(9323):2117-8; author reply 2118. PubMed ID: 12086795
    [No Abstract]   [Full Text] [Related]  

  • 28. The ADVANCE trial.
    Procopiou M
    Lancet; 2008 Jan; 371(9606):25; author reply 26. PubMed ID: 18177767
    [No Abstract]   [Full Text] [Related]  

  • 29. HOPE for diabetes in the new millennium. Heart Outcomes Prevention Evaluation.
    Donnelly R
    Diabetes Obes Metab; 2000 Jan; 2(1):1-2. PubMed ID: 11220348
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ramipril can do more. Halting progression of atherosclerosis].
    MMW Fortschr Med; 2001 Sep; 143(35-36):45. PubMed ID: 11584530
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comprehensive organoprotection in patients with high cardiovascular risk: the possibility of ramipril from positions of evidence-based medicine].
    Gaĭsenok OV; Marcevich SIu; Belolipetskaia VG
    Kardiologiia; 2013; 53(9):90-4. PubMed ID: 24090393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation.
    Kleinert S
    Lancet; 1999 Sep; 354(9181):841. PubMed ID: 10485736
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of a converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients].
    Hébert M
    Presse Med; 2000 Apr; 29(14):790-2. PubMed ID: 10816721
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dangerous plaque often symptom-free. ACE inhibitors prevent rupture].
    MMW Fortschr Med; 2002 Aug; 144(33-34):52. PubMed ID: 12380145
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
    Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ramipril: the better angiotensin-converting enzyme inhibitor?
    Gupta R
    Indian Heart J; 2008; 60(3):188-91. PubMed ID: 19240304
    [No Abstract]   [Full Text] [Related]  

  • 37. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

  • 38. Trials and tribulations in adult congenital heart disease.
    Dimopoulos K
    Int J Cardiol; 2008 Sep; 129(2):160-2. PubMed ID: 18692920
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Corner points of antihypertensive therapy in prediabetic state. Success with a combination].
    MMW Fortschr Med; 2003 Jul; 145(27-28):53. PubMed ID: 14587192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.